David J. Goldhamer

Affiliations: 
University of Pennsylvania, Philadelphia, PA, United States 
Area:
Molecular Biology, Cell Biology
Google:
"David Goldhamer"
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Burdick LN, DelVichio AH, Hanson LR, et al. (2024) Sex as a Critical Variable in Basic and Pre-Clinical Studies of Fibrodysplasia Ossificans Progressiva. Biomolecules. 14
Yamamoto M, Stoessel SJ, Yamamoto S, et al. (2022) Over-expression of wild-type ACVR1 in fibrodysplasia ossificans progressiva mice rescues perinatal lethality and inhibits heterotopic ossification. Journal of Bone and Mineral Research : the Official Journal of the American Society For Bone and Mineral Research
Lees-Shepard JB, Stoessel SJ, Chandler JT, et al. (2022) An anti-ACVR1 antibody exacerbates heterotopic ossification by fibro-adipogenic progenitors in fibrodysplasia ossificans progressiva mice. The Journal of Clinical Investigation
Yagi M, Ji F, Charlton J, et al. (2021) Dissecting dual roles of MyoD during lineage conversion to mature myocytes and myogenic stem cells. Genes & Development
Wood WM, Otis C, Etemad S, et al. (2020) Development and patterning of rib primordia are dependent on associated musculature. Developmental Biology
Fortin J, Tian R, Zarrabi I, et al. (2020) Mutant ACVR1 Arrests Glial Cell Differentiation to Drive Tumorigenesis in Pediatric Gliomas. Cancer Cell
Joseph GA, Hung M, Goel AJ, et al. (2019) Late-onset megaconial myopathy in mice lacking group I Paks. Skeletal Muscle. 9: 5
Goldhamer DJ, Lees-Shepard JB. (2019) Response to comment on 'Palovarotene reduces heterotopic ossification in juvenile FOP mice but exhibits pronounced skeletal toxicity'. Elife. 8
Lees-Shepard JB, Nicholas SE, Stoessel SJ, et al. (2018) Palovarotene reduces heterotopic ossification in juvenile FOP mice but exhibits pronounced skeletal toxicity. Elife. 7
Yamamoto M, Legendre NP, Biswas AA, et al. (2018) Loss of MyoD and Myf5 in Skeletal Muscle Stem Cells Results in Altered Myogenic Programming and Failed Regeneration. Stem Cell Reports
See more...